Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5875.00 | 5895.50 | 0.9965 | 0.9867 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5921.00 | 5895.50 | 1.0043 | 1.0166 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5773.00 | 5895.50 | 0.9792 | 0.9214 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5315.00 | 5895.50 | 0.9015 | 0.6407 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5720.00 | 5895.50 | 0.9702 | 0.8878 | |
| SK-BR-3 | Taxol | 0.00033113 | uM | 3 | 5000.00 | 4101.40 | 5973.00 | 5895.50 | 1.0131 | 1.0505 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 3 | 5000.00 | 4101.40 | 5935.00 | 5895.50 | 1.0067 | 1.0257 |
| SK-BR-3 | Omipalisib | 1 | uM | 3 | 5000.00 | 4101.40 | 2360.00 | 5895.50 | 0.4003 | -0.6521 |
| SK-BR-3 | Methotrexate | 10 | uM | 3 | 5000.00 | 4101.40 | 3225.00 | 5895.50 | 0.5470 | -0.3682 |
| SK-BR-3 | Palbociclib | 1 | uM | 3 | 5000.00 | 4101.40 | 4263.00 | 5895.50 | 0.7231 | 0.0766 |
| SK-BR-3 | Methotrexate | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 3300.00 | 5895.50 | 0.5598 | -0.3399 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 3 | 5000.00 | 4101.40 | 5592.00 | 5895.50 | 0.9485 | 0.8079 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 3 | 5000.00 | 4101.40 | 4438.00 | 5895.50 | 0.7528 | 0.1626 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 2800.00 | 5895.50 | 0.4749 | -0.5177 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 6117.00 | 5895.50 | 1.0376 | 1.1460 | |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 4640.00 | 5895.50 | 0.7870 | 0.2658 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 3 | 5000.00 | 4101.40 | 4046.00 | 5895.50 | 0.6863 | -0.0256 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5841.00 | 5895.50 | 0.9908 | 0.9648 | |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 4798.00 | 5895.50 | 0.8138 | 0.3494 |
| SK-BR-3 | Taxol | 0.1 | uM | 3 | 5000.00 | 4101.40 | 2079.00 | 5895.50 | 0.3526 | -0.7269 |
| SK-BR-3 | Taxol | 0.001 | uM | 3 | 5000.00 | 4101.40 | 5782.00 | 5895.50 | 0.9808 | 0.9271 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 4309.00 | 5895.50 | 0.7309 | 0.0989 |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 5009.00 | 5895.50 | 0.8496 | 0.4650 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 3 | 5000.00 | 4101.40 | 4026.00 | 5895.50 | 0.6829 | -0.0348 |
| SK-BR-3 | Omipalisib | 10 | uM | 3 | 5000.00 | 4101.40 | 2029.00 | 5895.50 | 0.3442 | -0.7393 |